NasdaqCM - Nasdaq Real Time Price USD
Cadrenal Therapeutics, Inc. (CVKD)
14.45
-1.05
(-6.77%)
At close: May 9 at 4:00:00 PM EDT
15.17
+0.72
+(4.98%)
After hours: May 9 at 5:29:54 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -1.26 | -1.39 | -5.76 | 0 |
| Low Estimate | -1.26 | -1.39 | -5.76 | 0 |
| High Estimate | -1.26 | -1.39 | -5.76 | 0 |
| Year Ago EPS | -2.25 | -2.18 | -8.73 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -1.8 | -1.8 | -1.87 | -2.15 |
| EPS Actual | -2.25 | -2.18 | -8.73 | -2.09 |
| Difference | -0.45 | -0.38 | -6.87 | 0.06 |
| Surprise % | -25.00% | -21.11% | -368.10% | 2.79% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.26 | -1.39 | -5.76 | 0 |
| 7 Days Ago | -1.26 | -1.39 | -5.76 | 0 |
| 30 Days Ago | -1.26 | -1.39 | -5.76 | 0 |
| 60 Days Ago | -1.26 | -1.39 | -4.27 | 0 |
| 90 Days Ago | -1.26 | -1.39 | -4.27 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVKD | 44.00% | 36.24% | 34.02% | -- |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/9/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/14/2024 |
| Initiated | Noble Capital Markets: Outperform | 12/18/2023 |
| Initiated | HC Wainwright & Co.: Buy | 11/20/2023 |
Related Tickers
QNRX Quoin Pharmaceuticals, Ltd.
6.19
-3.43%
CRVO CervoMed Inc.
8.49
-4.61%
PRTG Portage Biotech Inc.
8.18
-9.31%
GNPX Genprex, Inc.
0.2853
-0.56%
FULC Fulcrum Therapeutics, Inc.
5.37
-0.74%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2534
-15.53%
EXOZ eXoZymes, Inc.
13.01
+2.68%
CHRO Channel Therapeutics Corporation
1.1000
-1.79%
FBRX Forte Biosciences, Inc.
6.38
+2.41%
DWTX Dogwood Therapeutics, Inc.
4.5600
0.00%